{"id":481789,"title":"Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance Document - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:32:08.153000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/comparative-pharmacokinetic-studies-orally-inhaled-products-2020.html?wbdisable=true","snippet":"Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance Document ( PDF version , 250 KB) Date adopted: December 21, 2020 Date posted: December 21, 2020 Effective date: December 21, 2020 On this page Introduction Policy objectives Policy statement Scope and…","rawSnapshotUrl":"/api/snapshots/raw/481789","browseUrl":"https://replay.healtharchive.ca/job-6/20260106173208/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/comparative-pharmacokinetic-studies-orally-inhaled-products-2020.html?wbdisable=true#ha_snapshot=481789","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}